Development and In Vitro-In Vivo Evaluation of Extended-release Multiple-unit Pellet System Tablets of Metoprolol Succinate

被引:0
|
作者
Reddy, G. Lakshmi Narayana [1 ]
Rajnarayana, K. [1 ]
Jayaveera, K. N. [2 ]
机构
[1] RA ChemPharma Ltd, Formulat Res & Dev, Hyderabad, Telangana, India
[2] Vemu Inst Technol, Dept Chem, Chitoor, Andhra Pradesh, India
关键词
Extended-release; metoprolol succinate; multiparticulates; multiple-unit pellet system tablets;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: To design, develop, and evaluate the metoprolol succinate extended-release (ER) multiple-unit pellet system (MUPS) tablets. Materials and Methods: Metoprolol succinate ER pellets were prepared using Wurster process. The impact of the various concentrations of polymer and plasticizers were studied. Further optimized metoprolol succinate ER pellets were compressed into MUPS tablets and evaluated for various physico-chemical and pharmacokinetic parameters. Results and Discussion: Metoprolol succinate ER MUPS tablets prepared by using 7.5% w/w of ethocel as release retardant and 15% w/w of the plasticizer with respect to the polymer. The release extended for 20 h. Conclusion: Research work indicates that the test formulation was able to extend the delivery of metoprolol in the desired rate.
引用
收藏
页码:S39 / S42
页数:4
相关论文
共 50 条
  • [31] A flexible technology for modified-release drugs: Multiple-unit pellet system (MUPS)
    Abdul, Shajahan
    Chandewar, Anil V.
    Jaiswal, Sunil B.
    JOURNAL OF CONTROLLED RELEASE, 2010, 147 (01) : 2 - 16
  • [32] Impact of gastrointestinal residence time of extended-release (ER) tablets on in vivo evaluation of ER tablets
    Tajiri, S.
    Kanamaru, T.
    Konno, T.
    Nakagami, H.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2010, 20 (03) : 213 - 218
  • [33] Biorelevant In Vitro Release Testing and In Vivo Study of Extended-Release Niacin Hydrophilic Matrix Tablets
    Milanowski, Bartlomiej
    Hejduk, Arkadiusz
    Bawiec, Marek A.
    Jakubowska, Emilia
    Urbanska, Agnieszka
    Wisniewska, Anna
    Garbacz, Grzegorz
    Lulek, Janina
    AAPS PHARMSCITECH, 2020, 21 (03)
  • [34] Assessing the bioequivalence of over-the-counter esomeprazole banded capsules and multiple-unit pellet system tablets
    Vegesna, Vani
    Li, Jing
    Pollack, Charles
    Moreira, Sebastian
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (02) : 92 - 99
  • [35] Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation
    Kim, Tae Hwan
    Shin, Soyoung
    Bulitta, Jurgen B.
    Youn, Yu Seok
    Yoo, Sun Dong
    Shin, Beom Soo
    MOLECULAR PHARMACEUTICS, 2017, 14 (01) : 53 - 65
  • [36] In vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin
    Maroni, Alessandra
    Del Curto, Maria Dorly
    Salmaso, Stefano
    Zema, Lucia
    Melocchi, Alice
    Caliceti, Paolo
    Gazzaniga, Andrea
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 108 : 76 - 82
  • [37] Design and in vitro/in vivo evaluation of extended release matrix tablets of nateglinide
    Sharma, Pushkar R.
    Lewis, Shaila A.
    JOURNAL OF YOUNG PHARMACISTS, 2013, 5 (04) : 167 - 172
  • [38] Innovative intragastric ascaridole floating tablets: Development, optimization, and in vitro-in vivo evaluation
    Zhao, Qiang
    Gao, Baoan
    Ma, Lulu
    Lian, Jianhao
    Deng, Li
    Chen, Jianming
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 496 (02) : 432 - 439
  • [39] Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
    Mohamed-Eslam F. Mohamed
    Sheryl Trueman
    Ahmed A. Othman
    Jian-Hwa Han
    Tzuchi R. Ju
    Patrick Marroum
    The AAPS Journal, 21
  • [40] Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients
    Hamman, Hannlie
    Hamman, Josias
    Wessels, Anita
    Scholtz, Jacques
    Steenekamp, Jan
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2019, 24 (02) : 145 - 156